BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38619104)

  • 1. Stereospecific NANOG PEST Stabilization by Pin1.
    Ferreon JC; Ta HM; Yun H; Choi KJ; Quan MD; Tsoi PS; Kim C; Lee CW; Ferreon ACM
    Biochemistry; 2024 May; 63(9):1067-1074. PubMed ID: 38619104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neighboring phosphoSer-Pro motifs in the undefined domain of IRAK1 impart bivalent advantage for Pin1 binding.
    Rogals MJ; Greenwood AI; Kwon J; Lu KP; Nicholson LK
    FEBS J; 2016 Dec; 283(24):4528-4548. PubMed ID: 27790836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and Affinity of Pin1 Variants.
    Born A; Henen MA; Vögeli B
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Minichromosome Maintenance Protein 3 (MCM3) Chromatin Binding by the Prolyl Isomerase Pin1.
    Schumann M; Malešević M; Hinze E; Mathea S; Meleshin M; Schutkowski M; Haehnel W; Schiene-Fischer C
    J Mol Biol; 2018 Dec; 430(24):5169-5181. PubMed ID: 30316783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncorrelated Effect of Interdomain Contact on Pin1 Isomerase Activity Reveals Positive Catalytic Cooperativity.
    Zhu W; Li Y; Liu M; Zhu J; Yang Y
    J Phys Chem Lett; 2019 Mar; 10(6):1272-1278. PubMed ID: 30821977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupled intra- and interdomain dynamics support domain cross-talk in Pin1.
    Zhang M; Frederick TE; VanPelt J; Case DA; Peng JW
    J Biol Chem; 2020 Dec; 295(49):16585-16603. PubMed ID: 32963105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Peptidyl-Prolyl
    Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
    Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1.
    Moretto-Zita M; Jin H; Shen Z; Zhao T; Briggs SP; Xu Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13312-7. PubMed ID: 20622153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naturally occurring charged mutations on the structure, stability, and binding of the Pin1 WW domain.
    Qiao X; Liu Y; Luo L; Chen L; Zhao C; Ai X
    Biochem Biophys Res Commun; 2017 May; 487(2):470-476. PubMed ID: 28431929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Impact of Pin1 Catalytic Loop Phosphorylation Revealed by S71E Phosphomimetic.
    Mahoney BJ; Zhang M; Zintsmaster JS; Peng JW
    J Mol Biol; 2018 Mar; 430(5):710-721. PubMed ID: 29317221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of the Pin1-Histone H1 Interaction.
    Jinasena D; Simmons R; Gyamfi H; Fitzkee NC
    Biochemistry; 2019 Feb; 58(6):788-798. PubMed ID: 30507159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide binding induces large scale changes in inter-domain mobility in human Pin1.
    Jacobs DM; Saxena K; Vogtherr M; Bernado P; Pons M; Fiebig KM
    J Biol Chem; 2003 Jul; 278(28):26174-82. PubMed ID: 12686540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism of Pin1-Tau Recognition and Catalysis.
    Eichner T; Kutter S; Labeikovsky W; Buosi V; Kern D
    J Mol Biol; 2016 May; 428(9 Pt A):1760-75. PubMed ID: 26996941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the benefit of bivalency in peptide ligand/pin1 interactions.
    Daum S; Lücke C; Wildemann D; Schiene-Fischer C
    J Mol Biol; 2007 Nov; 374(1):147-61. PubMed ID: 17931657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent resonance energy transfer -based biosensor for detecting conformational changes of Pin1.
    Hidaka M; Okabe E; Hatakeyama K; Zook H; Uchida C; Uchida T
    Biochem Biophys Res Commun; 2018 Oct; 505(2):399-404. PubMed ID: 30262141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
    Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
    FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation.
    Ikura T; Tochio N; Kawasaki R; Matsuzaki M; Narita A; Kikumoto M; Utsunomiya-Tate N; Tate SI; Ito N
    FEBS Lett; 2018 Sep; 592(18):3082-3091. PubMed ID: 30079475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent Interactions with Fbw7 and Pin1 Facilitate Recognition of c-Jun by the SCF
    Csizmok V; Montecchio M; Lin H; Tyers M; Sunnerhagen M; Forman-Kay JD
    Structure; 2018 Jan; 26(1):28-39.e2. PubMed ID: 29225075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate Sequence Determines Catalytic Activities, Domain-Binding Preferences, and Allosteric Mechanisms in Pin1.
    Momin M; Yao XQ; Thor W; Hamelberg D
    J Phys Chem B; 2018 Jun; 122(25):6521-6527. PubMed ID: 29851476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1-Nanog expression in human glioma is correlated with advanced tumor progression.
    Yang Y; Niu CS; Cheng CD
    Oncol Rep; 2013 Aug; 30(2):560-6. PubMed ID: 23708493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.